Search research articles
Contact Us
Filters
Showing results (251-260 of 301) with videos related to
Page
of 31
Sort By:
Cancer Research
|
February 5, 2009
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature
Emmanuelle Charafe-Jauffret, Christophe Ginestier, Flora Iovino, et al.
Breast Cancer Research : BCR
|
December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
BMC Cancer
|
May 4, 2007
Nectin-4 is a new histological and serological tumor associated marker for breast cancer
Stéphanie Fabre-Lafay, Florence Monville, Sarah Garrido-Urbani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2011
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction
Xi Wen Zhao, Ellen M van Beek, Karin Schornagel, et al.
Cancer Research
|
October 7, 2004
A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene
Huai-En Huang, Suet-Feung Chin, Christophe Ginestier, et al.
Plos One
|
January 14, 2014
Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling
Stéphanie Cornen, Arnaud Guille, José Adélaïde, et al.
Molecular Oncology
|
December 20, 2019
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers
François Bertucci, Charlotte Rypens, Pascal Finetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2013
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets
Steven J Van Laere, Naoto T Ueno, Pascal Finetti, et al.
Oncotarget
|
October 19, 2018
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Haematologica
|
October 3, 2009
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
Olivier Kosmider, Véronique Gelsi-Boyer, Marion Ciudad, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 301) with videos related to
Sort By:
Page
of 31
Cancer Research
|
February 5, 2009
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature
Emmanuelle Charafe-Jauffret, Christophe Ginestier, Flora Iovino, et al.
Breast Cancer Research : BCR
|
December 9, 2015
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, et al.
BMC Cancer
|
May 4, 2007
Nectin-4 is a new histological and serological tumor associated marker for breast cancer
Stéphanie Fabre-Lafay, Florence Monville, Sarah Garrido-Urbani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2011
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction
Xi Wen Zhao, Ellen M van Beek, Karin Schornagel, et al.
Cancer Research
|
October 7, 2004
A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene
Huai-En Huang, Suet-Feung Chin, Christophe Ginestier, et al.
Plos One
|
January 14, 2014
Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling
Stéphanie Cornen, Arnaud Guille, José Adélaïde, et al.
Molecular Oncology
|
December 20, 2019
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers
François Bertucci, Charlotte Rypens, Pascal Finetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2013
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets
Steven J Van Laere, Naoto T Ueno, Pascal Finetti, et al.
Oncotarget
|
October 19, 2018
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Haematologica
|
October 3, 2009
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
Olivier Kosmider, Véronique Gelsi-Boyer, Marion Ciudad, et al.
Page
of 31